QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2020, 卷号: 8 作者:  Huang, Minran;  Jin, Jiaoyue;  Zhang, Fanrong;  Wu, Yingxue;  Xu, Chenyang 收藏  |  浏览/下载：29/0  |  提交时间：2020/11/26 Esophageal squamous cell carcinoma (ESCC)  TP53 mutation  next-generation sequencing (NGS)  prognosis   Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation 期刊论文 ONCOGENE, 2020, 卷号: 39 作者:  Jin, Ying;  Bao, Hua;  Le, Xiuning;  Fan, Xiaojun;  Tang, Ming 收藏  |  浏览/下载：25/0  |  提交时间：2020/11/26 Quantitative multi-omics analysis of the effects of mitochondrial dysfunction on lipid metabolism in Saccharomyces cerevisiae 期刊论文 APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 卷号: 104, 期号: 3, 页码: 1211-1226 作者:  Guo, Xiaopeng;  Zhang, Miaomiao;  Gao, Yue;  Cao, Guozhen;  Lu, Dong 收藏  |  浏览/下载：14/0  |  提交时间：2022/01/19 Multi-omics analysis  Mitochondria  Lipid metabolism  Respiration-deficient mutant  Saccharomyces cerevisiae   EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 页码: 15 作者:  Qin, Jianhua;  Liu, Yang;  Yin, Yalei;  Sun, Mingju;  Zhan, Xi 收藏  |  浏览/下载：107/0  |  提交时间：2019/06/20 Bromodomain  JQ1  MAPK pathway  MYC  EGFR mutation  Sorafenib   Egfr signaling confers resistance to bet inhibition in hepatocellular carcinoma through stabilizing oncogenic myc 期刊论文 Journal of experimental & clinical cancer research, 2019, 卷号: 38, 页码: 15 作者:  Yin, Yalei;  Sun, Mingju;  Zhan, Xi;  Wu, Changqing;  Geng, Pengyu 收藏  |  浏览/下载：137/0  |  提交时间：2019/05/08 Bromodomain  Jq1  Mapk pathway  Myc  Egfr mutation  Sorafenib   The Co-Occurring Genomic Landscape of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 10, 页码: S412-S412 作者:  Yuan, B.;  Zhao, J.;  Zhou, C.;  Wang, X.;  Zhu, B. 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/11 Afatinib  ERBB2 exon 20 insertion  concurrent mutation   The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms 期刊论文 IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2018, 卷号: 15, 期号: 3, 页码: 988-998 作者:  Zhang, Junhua;  Zhang, Shihua 收藏  |  浏览/下载：19/0  |  提交时间：2018/07/30 Bioinformatics  cancer genomics  driver gene  driver pathway  mutual exclusivity  co-occurring mutation   Discovery of co-occurring driver pathways in cancer 期刊论文 BMC Bioinformatics, 2014, 卷号: 15, 期号: 1 作者:  Zhang,Junhua;  Wu,Ling-Yun;  Zhang,Xiang-Sun;  Zhang,Shihua 收藏  |  浏览/下载：13/0  |  提交时间：2018/07/30